David Domzalski - Net Worth and Insider Trading
David Domzalski Net Worth
The estimated net worth of David Domzalski is at least $631,608 dollars as of 2025-01-12. David Domzalski is the CEO of Foamix Pharmaceuticals Ltd and owns about 211,240 shares of Foamix Pharmaceuticals Ltd (FOMX) stock worth over $631,608. Details can be seen in David Domzalski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Domzalski has not made any transactions after 2019-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Domzalski
David Domzalski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Domzalski owns 2 companies in total, including VYNE Therapeutics Inc (VYNE) , and Foamix Pharmaceuticals Ltd (FOMX) .
Click here to see the complete history of David Domzalski’s form 4 insider trades.
Insider Ownership Summary of David Domzalski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VYNE | VYNE Therapeutics Inc | 2020-03-09 | director & President and CEO |
| FOMX | Foamix Pharmaceuticals Ltd | 2020-03-09 | director & CEO |
David Domzalski Latest Holdings Summary
David Domzalski currently owns a total of 1 stock. David Domzalski owns 211,240 shares of Foamix Pharmaceuticals Ltd (FOMX) as of July 1, 2019, with a value of $631,608.
Latest Holdings of David Domzalski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOMX | Foamix Pharmaceuticals Ltd | 2019-07-01 | 211,240 | 2.99 | 631,608 |
Holding Weightings of David Domzalski
David Domzalski Form 4 Trading Tracker
According to the SEC Form 4 filings, David Domzalski has made a total of 0 transactions in Foamix Pharmaceuticals Ltd (FOMX) over the past 5 years. The most-recent trade in Foamix Pharmaceuticals Ltd is the sale of 3,355 shares on July 1, 2019, which brought David Domzalski around $7,884.
Insider Trading History of David Domzalski
- 1
David Domzalski Trading Performance
David Domzalski Ownership Network
Ownership Network List of David Domzalski
Ownership Network Relation of David Domzalski
David Domzalski Owned Company Details
What does VYNE Therapeutics Inc do?
Who are the key executives at VYNE Therapeutics Inc?
David Domzalski is the director & President and CEO of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .
VYNE Therapeutics Inc (VYNE) Insider Trades Summary
Over the past 18 months, David Domzalski made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 13,000 shares made by Patrick G Lepore ,
In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.
VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
VYNE Therapeutics Inc Insider Transactions
David Domzalski Mailing Address
Above is the net worth, insider trading, and ownership report for David Domzalski. You might contact David Domzalski via mailing address: C/o Foamix Pharmaceuticals Ltd., 2 Holzman Street, Weizmann Science Park, Rehovot L3 76704.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
